AYTU - Company ID 0001385818
AYTU BIOPHARMA, INC (AYTU) reported revenue of $57.57M for fiscal year 2026, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2026 | $57.57M | -13.3% |
| FY 2025 | $66.38M | +1.8% |
| FY 2024 | $65.18M | -39.3% |
| FY 2023 | $107.40M | +11.1% |
| FY 2022 | $96.67M | +47.3% |
| FY 2021 | $65.63M | +137.5% |
| FY 2020 | $27.63M | +277.5% |
| FY 2019 | $7.32M | +100.0% |
| FY 2018 |
AYTU BIOPHARMA, INC (AYTU) reported revenue of $57.57M for fiscal year 2026, as filed in its audited annual report with the SEC.
Between fiscal 2014 and fiscal 2026, AYTU BIOPHARMA, INC's revenue grew from $58.93K to $57.57M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.66M |
| +13.6% |
| FY 2017 | $3.22M | +25.7% |
| FY 2016 | $2.56M | +878.8% |
| FY 2015 | $261.78K | +344.2% |
| FY 2014 | $58.93K | - |